apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Adverse events 2.0-Let us get SERIOs New reporting for adverse event outcomes needed in the era of immunooncology (2019) Heinzerling L, Ascierto PA, Dummer R, Gogas H, Grob JJ, Lebbe C, Long GV, et al. Journal article, Letter Age as a Key Factor in the Pattern, Extent and timing Process of Distant Metastasis in Patients with malignant Melanoma. A Study by the German Central Register of Malignant Melanoma (2019) Gassenmaier M, Leiter U, Eigentler T, Roecken M, Keim U, Gesierich A, Moritz R, et al. Conference contribution Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry (2019) Gassenmaier M, Keim U, Leiter U, Eigentler TK, Roecken M, Gesierich A, Moritz RKC, et al. Journal article Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma (2019) Krueckel A, Moreira A, Froehlich W, Schuler G, Heinzerling L Journal article Senescence markers: Predictive for response to checkpoint inhibitors (2019) Moreira A, Gross S, Kirchberger MC, Erdmann M, Schuler G, Heinzerling L Journal article Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma (2019) Riethdorf S, Hildebrandt L, Heinzerling L, Heitzer E, Fischer N, Bergmann S, Mauermann O, et al. Journal article Sequence-dependent cross-resistance of combined radiotherapy plus BRAF(V600E) inhibition in melanoma (2019) Shannan B, Matschke J, Chauvistre H, Vogel F, Klein D, Meier F, Westphal D, et al. Journal article Checkpoint Inhibitors The Diagnosis and Treatment of Side Effects (2019) Heinzerling L, De Toni EN, Schett G, Hundorfean G, Zimmer L Journal article, Review article Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors (2019) Awadalla M, Golden DLA, Mahmood SS, Alvi RM, Mercaldo ND, Hassan MZO, Banerji D, et al. Journal article Predicting the response of uveal melanoma to immunotherapy with MRI assessments (2019) Moreira A, Saake M, Schuler G, Heinzerling L Conference contribution